scispace - formally typeset
B

Baomin Shi

Researcher at Tongji University

Publications -  28
Citations -  359

Baomin Shi is an academic researcher from Tongji University. The author has contributed to research in topics: Pancreatic cancer & Hepatocellular carcinoma. The author has an hindex of 10, co-authored 23 publications receiving 264 citations. Previous affiliations of Baomin Shi include Shandong University & Charité.

Papers
More filters
Journal ArticleDOI

Surgical strategies for treatment of malignant pancreatic tumors: extended, standard or local surgery?

TL;DR: For patients with small or low-grade malignant neoplasms, as well as small pancreatic metastases located in the mid-portion of pancreas, central pancreatectomy (CP) is emerging as a safe and effective option with a low risk of developing de-novo exocrine and/or endocrine insufficiency.
Journal ArticleDOI

Anticancer effects of miR-124 delivered by BM-MSC derived exosomes on cell proliferation, epithelial mesenchymal transition, and chemotherapy sensitivity of pancreatic cancer cells.

TL;DR: MiR-124-carried BM-MSC-derived exosomes have potential applications for the treatment of pancreatic tumors and the effects on cell viability, apoptosis, invasion, migration and epithelial mesenchymal transition were evaluated.
Journal ArticleDOI

Value of portal hemodynamics and hypersplenism in cirrhosis staging.

TL;DR: An optimal system that includes parameters representing the portal hemodynamics and spleen function should be proposed for cirrhosis staging.
Journal ArticleDOI

Transplantation of monocyte-derived hepatocyte-like cells (NeoHeps) improves survival in a model of acute liver failure.

TL;DR: Hepatocyte transplantation is a practicable and successful treatment option in case of liver insufficiency because implantation of NeoHeps or primary rat hepatocytes had an improving effect on survival.
Journal ArticleDOI

Vascular endothelial growth factor attenuates hepatic sinusoidal capillarization in thioacetamide-induced cirrhotic rats.

TL;DR: Injection of a plasmid encoding VEGF through the portal vein is an effective method to induce the formation of fenestrae and decrease portal vein pressure in cirrhotic rats and may be a good choice for treating hepatic cirrhosis and portal hypertension.